488: Evaluating the unknown QTc/torsades risk of hydroxychloroquine and azithromycin
487: What is the difference between DKA and HHS?
486: Medications that have in vitro but otherwise unproven activity against COVID-19
485: Can etomidate be given as a continuous infusion?
484: Top takeways for hospital pharmacists from the NEJM editors discussion on treating Covid-19
483: Protocolized diuresis for deresuscitation
482: Should norepinephrine be started before fluid resuscitation is complete?
481: 10 tips for implementing a PGY-1 rotation experience
480: The effects of epinephrine infusion on survival in critically ill patients
479: Should patients with antibiotic-impregnated bone cement receive therapeutic drug monitoring?
478: Buprenorphine as an antidote in methadone overdose
- « Previous Page
- 1
- …
- 46
- 47
- 48
- 49
- 50
- …
- 88
- Next Page »